"Gene Therapeutics For Enhancement/Restoration Of Endometrial Function" in Patent Application Approval Process (USPTO 20230390365).
In: Gene Therapy Weekly, 2023-12-25, S. 2918-2918
serialPeriodical
Zugriff:
A patent application by Creative Medical Technologies Inc. has been made available online for a gene therapeutic method to prevent and treat endometrial atrophy. The method involves administering a gene therapeutic to the patient and adjusting the concentration and frequency based on the response. The gene therapeutic can be administered through various methods, such as into the ovarian artery or directly into the uterine lining. The gene therapeutic can have angiogenic, anti-apoptotic, or anti-fibrotic properties. This method aims to address infertility and age-related barriers to childbearing, which can have a significant impact on the emotional, mental, and spiritual well-being of women and couples. [Extracted from the article]
Copyright of Gene Therapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Gene Therapeutics For Enhancement/Restoration Of Endometrial Function" in Patent Application Approval Process (USPTO 20230390365).
|
---|---|
Zeitschrift: | Gene Therapy Weekly, 2023-12-25, S. 2918-2918 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1078-2842 (print) |
Schlagwort: |
|
Sonstiges: |
|